By dynamically monitoring 9 MNA NB after surgery, we found the M/N ratio greater than cut‐off value before 1–2 months, illustrating that the plasma MYCN amplification status can be used as a non‐invasive indicator of NB recurrence, although this conclusion requires more NB recurrences case proof. The gene discussed is MYCN; the disease is neuroblastoma.